Infectious disorder of the nervous system
MONDO:0020010A infectious disease that involves the nervous system.
Also known as: nervous system infectious disease, nervous system infectious disorder
219 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Next-Generation polio vaccine enters human testing
⭐️ VACCINE ⭐️ Not yet recruitingThis trial tests a new recombinant polio vaccine (rPV) against the current standard IPOL vaccine in healthy adults aged 18 to 60. The goal is to see if the new vaccine is safe and triggers a strong immune response. It is a small, early-stage study to gather initial data.
Phase: PHASE1 • Sponsor: Serum Institute of India Pvt. Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 12, 2026 00:00 UTC
-
No-Needle tetanus shot? new patch trial begins
⭐️ VACCINE ⭐️ Not yet recruitingThis first-in-human study tests a new microneedle patch (Miracus) that dissolves in the skin to deliver a tetanus vaccine without a needle. Thirty healthy adults will receive either an empty patch or one loaded with vaccine. Researchers will check safety, tolerability, and whethe…
Phase: PHASE4 • Sponsor: Microneedle Solutions Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 13:02 UTC
-
New vaccine for moms could shield babies from whooping cough
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new vaccine called TdaP2gen in 320 pregnant women in Thailand to see if it safely protects their babies from tetanus, diphtheria, and whooping cough. The vaccine is given during pregnancy, and researchers measure antibody levels in mothers and infants up to 18 …
Phase: PHASE4 • Sponsor: Chiang Mai University • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 13:01 UTC
-
New vaccine trial aims to shield teens and adults from whooping cough
⭐️ VACCINE ⭐️ Not yet recruitingThis early-stage trial is testing a new combination vaccine that protects against whooping cough, diphtheria, and tetanus (Tdap) in people aged 10 and older. Researchers want to see if different doses are safe and trigger an immune response. The study involves 96 volunteers and c…
Phase: PHASE1 • Sponsor: Changchun BCHT Biotechnology Co. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:00 UTC
-
Rabies vaccine booster still effective after 5 years, study to confirm
⭐️ VACCINE ⭐️ Not yet recruitingThis study checks if a single rabies booster shot can still protect people who got their first rabies vaccine at least 5 years ago. About 561 healthy adults will get a booster, and researchers will measure their immune response after 7 days. The goal is to see if different initia…
Phase: PHASE3 • Sponsor: Institute of Tropical Medicine, Belgium • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:10 UTC
-
New Low-Dose tdap vaccine trial aims to boost protection with fewer side effects
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new version of the Tdap vaccine (which protects against tetanus, diphtheria, and whooping cough) that has reduced antigens. The goal is to see if it is safe and triggers a strong immune response in people aged 6 and up. Around 660 volunteers will receive either…
Phase: PHASE1, PHASE2 • Sponsor: Institute of Medical Biology, Chinese Academy of Medical Sciences • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:06 UTC
-
New meningitis vaccine enters first human tests
⭐️ VACCINE ⭐️ Not yet recruitingThis early-stage trial is testing a new vaccine designed to protect against several types of meningococcal bacteria, which can cause meningitis and bloodstream infections. Researchers will enroll 150 healthy people aged 2 to 59 to check the vaccine's safety and how well it trigge…
Phase: PHASE1 • Sponsor: Sinovac Life Sciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:00 UTC
-
Could a tiny skin shot replace the big rabies needle?
⭐️ VACCINE ⭐️ Not yet recruitingThis study compares two ways of giving the rabies vaccine: the standard shot in the muscle versus a smaller dose injected under the skin. Researchers want to see if the skin method works just as well and is as safe, while using less vaccine and costing less. About 90 healthy volu…
Phase: PHASE2, PHASE3 • Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:12 UTC
-
New rabies vaccine could cut shots from three visits to one
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new experimental rabies vaccine (ChAdOx2 RabG) given together with the standard rabies vaccine in healthy adults aged 18-45. The goal is to see if this combination is safe and produces a strong immune response, potentially allowing a single visit instead of the…
Phase: PHASE2 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:57 UTC
-
Could a shorter drug course beat a longer one for a deadly fungal infection?
Disease control Not yet recruitingThis trial is testing whether a 10-week course of fluconazole works as well as the standard 24-week course for people with HIV who have a cryptococcal infection in their blood (antigenemia) but no symptoms. It also compares starting HIV medications right away versus waiting 14 da…
Phase: PHASE3 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a cancer drug wake up immune cells to beat HIV-Related infections?
Disease control Not yet recruitingThis study tests a drug called Sintilimab, which is normally used for cancer, to see if it can help people with HIV who have infections that won't go away with standard treatment. The drug works by 'waking up' exhausted immune cells. Fifty adults with HIV and a hard-to-treat infe…
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Public Health Clinical Center • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Brain injection method could revolutionize meningitis treatment
Disease control Not yet recruitingThis study tests a new method of giving antibiotics for moderate-to-severe bacterial meningitis. Instead of only giving antibiotics through a vein, doctors will also inject them into the skull bone to help more medicine reach the brain. The goal is to improve recovery in 86 adult…
Phase: NA • Sponsor: yilong Wang • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could an HIV drug extend life in Creutzfeldt-Jakob disease?
Disease control Not yet recruitingThis study tests whether efavirenz, a drug used for HIV, can help people with Creutzfeldt-Jakob disease (CJD) live longer. CJD is a rare, rapidly fatal brain disorder. The trial will enroll 246 adults and randomly assign them to receive either efavirenz or a placebo. The main goa…
Phase: PHASE3 • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New drug duo takes on deadly brain infection
Disease control Not yet recruitingThis study tests a new two-drug combination (Alpibectir and Ethionamide) added to standard treatment for tuberculosis meningitis, a serious brain infection. About 64 adults newly diagnosed with the condition will receive the drugs to see how well they reach the brain and how safe…
Phase: PHASE2 • Sponsor: BioVersys AG • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New weapon against superbug pneumonia and blood infections
Disease control Not yet recruitingThis study tests a new antibiotic combination (BV100 plus other drugs) against hard-to-treat infections like pneumonia and bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii. About 120 adults in the hospital will receive either the new combo or the best…
Phase: PHASE2 • Sponsor: BioVersys AG • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New scope surgery may improve outcomes for babies with meningitis complications
Disease control Not yet recruitingThis study will compare two surgical methods for treating fluid collections in the brain that can occur after infant meningitis. One method uses a small camera (neuroendoscope) to remove debris and place a reservoir for drainage. The other is a standard burr hole drainage. The tr…
Sponsor: Shengjing Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Can a common antiviral tame herpes meningitis?
Disease control Not yet recruitingThis study tests whether the antiviral drug aciclovir (or its pill form valacyclovir) works better than a placebo for treating meningitis caused by the herpes simplex virus type 2 (HSV-2). About 150 adults with confirmed HSV-2 meningitis will receive either the drug or a placebo,…
Phase: PHASE4 • Sponsor: Jacob Bodilsen • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Spit test could replace needles for tetanus check
Diagnosis Not yet recruitingThis study aims to create a quick, non-invasive test using saliva to see if someone has enough antibodies to fight tetanus. Instead of drawing blood, a small saliva sample on a test strip would give results in 10-15 minutes. The test is designed for low- and middle-income areas w…
Phase: NA • Sponsor: University of Birmingham • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC
-
Rapid brain infection test could slash unnecessary antibiotic use
Diagnosis Not yet recruitingThis study looks at whether a quick diagnostic test (BioFire FilmArray) can accurately predict the cause of meningitis or encephalitis in 182 adults. Participants with symptoms like fever, headache, or confusion will have their spinal fluid tested. The goal is to see if the test …
Phase: NA • Sponsor: Federal University of Health Science of Porto Alegre • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
New shot aims to block deadly tetanus after dirty wounds
Prevention Not yet recruitingThis study tests a new medicine called SNA02-48 to see if it can prevent tetanus in people who have had a high-risk wound, like a deep cut or puncture from a dirty object. About 600 adults will receive either the new injection or the standard treatment (human tetanus immunoglobul…
Phase: PHASE3 • Sponsor: Sinovac Life Sciences Co., Ltd. • Aim: Prevention
Last updated Jun 27, 2026 13:04 UTC
-
Could a common steroid prevent a deadly complication in AIDS patients?
Prevention Not yet recruitingThis study tests whether a short course of the steroid prednisolone can prevent paradoxical immune reconstitution inflammatory syndrome (IRIS) in people with AIDS who have low CD4 counts and are starting HIV treatment. About 131 participants will receive either prednisolone or no…
Phase: NA • Sponsor: Shanghai Public Health Clinical Center • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
New rabies shot could shield millions after bites
Prevention Not yet recruitingThis study tests a lab-made antibody injection designed to prevent rabies after exposure. About 200 healthy adults aged 18-60 will receive the injection to check its safety and how well it boosts rabies-fighting antibodies. The goal is to find a reliable treatment that can be use…
Phase: PHASE2 • Sponsor: Lanzhou Institute of Biological Products Co., Ltd • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC
-
Rabies vaccine batch check: will it pass the test?
Prevention Not yet recruitingThis study tests whether three different batches of a rabies vaccine work the same way and are safe. It involves 912 healthy adults aged 18 to 45. The goal is to make sure every batch produces a strong immune response.
Phase: PHASE3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: Prevention
Last updated Jun 27, 2026 09:05 UTC
-
New antibody shot could shield against Tick-Borne brain virus
Prevention Not yet recruitingThis early-stage study tests a lab-made antibody called TBE025 in 18 healthy adults aged 18 to 55. The goal is to see if it is safe and how the body processes it when given through a vein. Participants receive one dose and are closely monitored for side effects. This research hel…
Phase: PHASE1 • Sponsor: Giuseppe Pantaleo • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
Will a single DTP vaccine dose protect for a decade? study tracks antibodies
Knowledge-focused Not yet recruitingThis study follows 160 people who previously received a 5-component DTP vaccine (protecting against diphtheria, tetanus, and pertussis) to see how long their immune protection lasts. Blood samples are taken at 2.5, 5, and 10 years after vaccination to measure antibody levels. The…
Sponsor: CanSino Biologics Inc. • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Could a single meningitis shot protect for years? a study investigates
Knowledge-focused Not yet recruitingThis study follows 180 children who received a meningitis vaccine (ACYW135 conjugate) years ago to see if their immune protection lasts. Researchers will measure antibody levels in blood samples taken 3 and 5 years after vaccination. The goal is to understand how long immunity pe…
Sponsor: CanSino Biologics Inc. • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Can a Long-Term watch program unlock the secrets of genetic prion disease?
Knowledge-focused Not yet recruitingThis study follows adults with a family history of genetic prion disease to see how and when the condition first appears. Participants undergo regular check-ins and genetic testing over many years. The goal is to map the natural course of the disease and identify early markers th…
Sponsor: University Hospitals Cleveland Medical Center • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC
-
New study uses DNA to track hidden gonorrhea in partners
Knowledge-focused Not yet recruitingThis study will recruit 100 sexual partners of people diagnosed with gonorrhea. Researchers will take an extra throat swab to analyze all the bacteria and their genes using a technique called metagenomics. The goal is to find hidden infections, antibiotic resistance, and see how …
Sponsor: Guy's and St Thomas' NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
New study aims to understand physical challenges in kids with nerve diseases
Knowledge-focused Not yet recruitingThis study will look at balance, core strength, leg strength, walking ability, and fatigue in 32 children aged 6-18 with demyelinating diseases (conditions affecting the protective coating of nerves). Each child will undergo a single session of non-invasive tests like balance exe…
Sponsor: Istanbul University - Cerrahpasa • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New study seeks clues to recovery in rare childhood brain condition
Knowledge-focused Not yet recruitingThis study aims to find what factors predict recovery in children with acute disseminated encephalomyelitis (ADEM), a rare brain condition. Researchers will follow 25 children aged 6 months to 18 years to see how many recover fully and how many have relapses. The study does not t…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Spinal infection study aims to measure Real-World recovery rates
Knowledge-focused Not yet recruitingThis observational study will follow 50 patients with primary spondylodiscitis, a serious spinal infection, for one year. Researchers will track cure rates, pain levels, and daily function using standard treatments like antibiotics and braces. The goal is to understand how well c…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Blood test may replace brain surgery for infection diagnosis
Knowledge-focused Not yet recruitingThis study explores whether a blood test can identify the bacteria causing a brain abscess, potentially avoiding the need for brain surgery to get a sample. Researchers will compare the germs found in the blood with those found in the abscess during surgery in 15 adults. If succe…
Phase: NA • Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
New study tracks brain health in kids after stem cell transplants
Knowledge-focused Not yet recruitingThis observational study will follow 100 children in Denmark who receive a stem cell transplant for blood cancer or other serious blood disorders. Researchers will test their thinking skills, physical abilities, and daily activity before the transplant and for one year after. The…
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Do childhood vaccines last? 5-year follow-up study launched in china
Knowledge-focused Not yet recruitingThis study follows 600 Chinese children who received standard vaccines against polio, measles, mumps, rubella, and hepatitis A. Researchers will test their blood to see if protective antibodies remain 5 years after vaccination. The goal is to understand how long vaccine protectio…
Sponsor: China National Biotec Group Company Limited • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
AI vs. experts: can a computer judge speech as well as a human?
Knowledge-focused Not yet recruitingThis study will compare how well an AI program (Blings) measures speech clarity in 40 adults with speech disorders from stroke or other neurological conditions. Two speech therapists will also rate the same speech samples. The goal is to see if the AI can reliably replace or assi…
Sponsor: Pusan National University Yangsan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
New study aims to spot which kids with rare brain inflammation will recover fully
Knowledge-focused Not yet recruitingThis study will follow 32 children diagnosed with their first episode of acute disseminated encephalomyelitis (ADEM), a rare brain inflammation that usually follows an infection. Researchers will check if early MRI scans, spinal fluid tests, and symptoms can predict which childre…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Silent threat: study to uncover hidden spread of brain infection in cambodian kids
Knowledge-focused Not yet recruitingThis study will follow 4,000 children in Cambodia to understand how common Japanese Encephalitis (JE) is and how often it spreads without symptoms. Researchers will compare healthy children with those hospitalized for fever and brain-related symptoms. The goal is to measure the t…
Sponsor: ANRS, Emerging Infectious Diseases • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:48 UTC
-
New study aims to uncover why some kids face brain fog after bone marrow transplant
Knowledge-focused Not yet recruitingThis study will follow 175 children and young adults who had a bone marrow transplant before age 18. Researchers will test their thinking, memory, and attention skills, and check for links to physical health issues like metabolism and fitness. The goal is to find early warning si…
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:59 UTC